A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to follow up patients, who have achieved complete clearance of AK
lesions (lesion count of 0) at Day 57 in the PEP005-020 study, over a 12 month period to
assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected
treatment area.